SmallCaps
HomeLatest News

Latest News

Breaking news and real-time updates from the ASX small-cap market

Mithril Silver and Gold Confirms 550m of Strike at Copalquin-Zaragoza Structure
Mining & Resources

Mithril Silver and Gold Confirms 550m of Strike at Copalquin-Zaragoza Structure

X2M Connect Lands First High-Density GPU Data Centre Contract Valued at More than $250m
Technology

X2M Connect Lands First High-Density GPU Data Centre Contract Valued at More than $250m

Aland Equity Group Targets $32m Annual Income from Chinnerys and Cowra Developments
Industrials & Juniors

Aland Equity Group Targets $32m Annual Income from Chinnerys and Cowra Developments

Horizon Oil Delivers Record FY26 Production as Expanded Portfolio Sets Up Growth
Energy

Horizon Oil Delivers Record FY26 Production as Expanded Portfolio Sets Up Growth

Power Minerals Intersects High-Grade REEs in Maiden Drilling at Morro do Ferro
Mining & Resources

Power Minerals Intersects High-Grade REEs in Maiden Drilling at Morro do Ferro

Infragreen Group Posts Record FY26 Earnings as Energybuild Leads Growth
Industrials & Juniors

Infragreen Group Posts Record FY26 Earnings as Energybuild Leads Growth

DevEx Resources Builds Nabarlek Uranium Pipeline as KP Alteration Strengthens Target
Mining & Resources

DevEx Resources Builds Nabarlek Uranium Pipeline as KP Alteration Strengthens Target

Maritana Minerals Extends High-Grade Burbanks Footprint Below Main Lode
Mining & Resources

Maritana Minerals Extends High-Grade Burbanks Footprint Below Main Lode

Rapid Critical Metals Extends Silver System 300m South of Current Webbs Resource
Mining & Resources

Rapid Critical Metals Extends Silver System 300m South of Current Webbs Resource

Estrella Resources Identifies Additional Copper Mineralisation at Laleno Dome
Mining & Resources

Estrella Resources Identifies Additional Copper Mineralisation at Laleno Dome

Wisr Turns Cash NPAT Positive as FY26 Originations Surge 65%
Industrials & Juniors

Wisr Turns Cash NPAT Positive as FY26 Originations Surge 65%

Preclinical Data Shows Noxopharm’s Sofra Technology Can Enhance Current Cancer Treatments
Biotechnology

Preclinical Data Shows Noxopharm’s Sofra Technology Can Enhance Current Cancer Treatments